BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25816991)

  • 21. Does preoperative measurement of cerebral blood flow with acetazolamide challenge in addition to preoperative measurement of cerebral blood flow at the resting state increase the predictive accuracy of development of cerebral hyperperfusion after carotid endarterectomy? Results from 500 cases with brain perfusion single-photon emission computed tomography study.
    Oshida S; Ogasawara K; Saura H; Yoshida K; Fujiwara S; Kojima D; Kobayashi M; Yoshida K; Kubo Y; Ogawa A
    Neurol Med Chir (Tokyo); 2015; 55(2):141-8. PubMed ID: 25746308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of cerebral perfusion in moyamoya disease with dynamic pseudo-continuous arterial spin labeling using a variable repetition time scheme with optimized background suppression.
    Togao O; Obara M; Yamashita K; Kikuchi K; Arimura K; Nishimura A; Nakamizo A; Wada T; Tokunaga C; Mikayama R; Yamashita Y; Hamano H; Van Cauteren M; Ishigami K; Baba S
    Neuroradiology; 2023 Mar; 65(3):529-538. PubMed ID: 36434310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the dual-table autoradiographic method to quantify two sequential rCBFs in a single SPET session with N-isopropyl-[123I] p-iodoamphetamine.
    Nishizawa S; Iida H; Tsuchida T; Ito H; Konishi J; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):943-50. PubMed ID: 12734690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
    Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
    World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of the regional cerebral blood flow and vascular reserve in moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography.
    Honda M; Ezaki Y; Kitagawa N; Tsutsumi K; Ogawa Y; Nagata I
    Surg Neurol; 2006 Aug; 66(2):155-9; discussion 159. PubMed ID: 16876609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting PET Cerebrovascular Reserve with Deep Learning by Using Baseline MRI: A Pilot Investigation of a Drug-Free Brain Stress Test.
    Chen DYT; Ishii Y; Fan AP; Guo J; Zhao MY; Steinberg GK; Zaharchuk G
    Radiology; 2020 Sep; 296(3):627-637. PubMed ID: 32662761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of rate of increase in SPECT counts in one-day method of N-isopropyl-4-iodoamphetamine [123I] SPECT studies at rest and after acetazolamide challenge using a method for estimating time-dependent distribution at rest.
    Kawamura Y; Ashizaki M; Saida S; Sugimoto H
    Ann Nucl Med; 2008 Jun; 22(5):457-63. PubMed ID: 18600426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Arterial Transit Time and Cerebrovascular Reactivity in Moyamoya Disease by Simultaneous PET/MRI.
    Takata K; Kimura H; Ishida S; Isozaki M; Higashino Y; Kikuta KI; Okazawa H; Tsujikawa T
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Measurement of cerebral blood flow with 99mTc-ECD SPECT and its potential clinical implications--analyzing the relationships between CBF and lifestyle disease].
    Nemoto H; Nakai Y; Hatakeyama R; Shikano N; Jesmin S; Yamaguchi N
    Kaku Igaku; 2012 Nov; 49(4):329-40. PubMed ID: 23402203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short- and Long-Term MRI Assessed Hemodynamic Changes in Pediatric Moyamoya Patients After Revascularization.
    Zhao MY; Tong E; Duarte Armindo R; Fettahoglu A; Choi J; Bagley J; Yeom KW; Moseley M; Steinberg GK; Zaharchuk G
    J Magn Reson Imaging; 2024 Apr; 59(4):1349-1357. PubMed ID: 37515518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Operator-bias-free comparison of quantitative perfusion maps acquired with pulsed-continuous arterial spin labeling and single-photon-emission computed tomography.
    Iwanaga T; Harada M; Kubo H; Funakoshi Y; Kunikane Y; Matsuda T
    Magn Reson Med Sci; 2014; 13(4):239-49. PubMed ID: 25167874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study.
    Qiao PG; Han C; Zuo ZW; Wang YT; Pfeuffer J; Duan L; Qian T; Li GJ
    J Neuroradiol; 2017 Jul; 44(4):273-280. PubMed ID: 28168990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial Spin Labeling MRI for Quantitative Assessment of Cerebral Perfusion Before and After Cerebral Revascularization in Children with Moyamoya Disease.
    Ha JY; Choi YH; Lee S; Cho YJ; Cheon JE; Kim IO; Kim WS
    Korean J Radiol; 2019 Jun; 20(6):985-996. PubMed ID: 31132824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of quantification analysis software for measuring regional cerebral blood flow by the modified split-dose method with (123)I-IMP before and after acetazolamide loading].
    Nagaki A; Kobara K; Matsutomo N
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2003 Dec; 59(12):1573-9. PubMed ID: 15001874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.
    Fan AP; Guo J; Khalighi MM; Gulaka PK; Shen B; Park JH; Gandhi H; Holley D; Rutledge O; Singh P; Haywood T; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2017 Sep; 48(9):2441-2449. PubMed ID: 28765286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced perfusion reserve in Leukoaraiosis demonstrated using acetazolamide challenge 123I-IMP SPECT.
    Tomura N; Sasaki K; Kidani H; Nishii T; Yasuda K; Ishiyama K; Otani T; Sakuma I; Takahashi S; Watarai J; Yanagisawa T; Mizoi K
    J Comput Assist Tomogr; 2007; 31(6):884-7. PubMed ID: 18043350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study.
    Saito N; Nakagawara J; Nakamura H; Teramoto A
    Ann Nucl Med; 2004 Jun; 18(4):323-31. PubMed ID: 15359926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity of the γ-Ray Evaluation with iodoamphetamine for Cerebral Blood Flow Assessment (REICA) method for quantification of cerebral blood flow including acetazolamide challenge test.
    Miyazaki Y; Kameyama M; Nakamizo A; Noguchi T; Tabata N
    Ann Nucl Med; 2022 Mar; 36(3):279-284. PubMed ID: 34973145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Hemodynamic Compromise Using Computed Tomography Perfusion in Combination with
    Hashimoto A; Mikami T; Komatsu K; Noshiro S; Hirano T; Wanibuchi M; Mikuni N
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):627-635. PubMed ID: 27939758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in cerebral blood flow measurement using arterial spin labeling MRI between patients with moyamoya disease and patients with arteriosclerotic cerebrovascular disease.
    Ueda Y; Tanaka Y; Hara S; Inaji M; Ishii K; Maehara T; Nariai T
    Acta Radiol; 2023 Jan; 64(1):311-319. PubMed ID: 35037475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.